Open access
Aug 2026
BRIX1 Promotes Hepatocellular Carcinoma Progression via the MAPK/ERK Pathway and Serves as a Prognostic Biomarker
Analysis of the expression pattern of BRIX1 in HCC from public gene expression databases and tissue samples from clinical HCC provides a rational clue for the further investigation of BRIX1 as an invaluable biological marker for diagnosing and predicting prognosis of patients with HCC.
Xianzhu Pan, Xiao-Qing Wang, Yuan-Qin Zhou
· bioRxiv · 0 citations